BrainStorm Seeking Approval To Distribute NurOwn® in Canada (Brainstorm Cell Therapeutics Inc)
(WorldNews Health)

(Source: Brainstorm Cell Therapeutics Inc) Signs agreement with CCRM for regulatory support of ALS treatment TORONTO, HACKENSACK, N.J. and PETACH TIKVAH, Israel, Feb. 21, 2017 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, has signed an agreement with CCRM, a Toronto-based leader in developing and commercializing regenerative medicine technologies, and cell and gene therapies, to support the market authorization request for NurOwn®. At this time, CCRM is helping Brainstorm explore the opportunity to access Health Canada`s early access pathway for treatment of patients with Amyotrophic...